Rep. James Commer, R-KY. , 23andME data privacy concerns, his invitation to testify in front of lawmakers by the Sanctuary Governor, and whether NPR and PB should strip the funds.
Bankruptcy 23andme faces a lawsuit over a plan to sell its client’s genetic information.
27 states and the District of Columbia have been taken Legal measures This week, against 23andMe in the US Bankruptcy Court in the Eastern District of Missouri, the court oversaw Chapter 11 bankruptcy proceedings that genetic testing companies invaded earlier this year.
23AndMe files are file for bankruptcy as California AG encourages customers to delete data
The state claims that 23andme “will not have the right to sell the customer’s genetic identity to the highest bidder unless the company first acquires it.”[s] Specify informed consent for transactions/transfer suggestions by each affected consumer. ”
Company representatives will showcase what is found in the DNA kit at the 23andMe booth at the Rowstech Annual Genealogical Event, held in Salt Lake City, Utah, February 28, 2019. (George Frey/Reuters)
They hope that the bankruptcy court will control whether genetic testing companies can first sell such intimate customer data and sell such intimate customer data and sell and transfer such intimate customer data, according to the filing.
In its submission, the state said it “doublely opposes sales,” but it claims that it “also claims that explicit informed consent by each customer is necessary prior to its transfer. Customer data You can do it. ”
The attorney general filed the lawsuit was Arizona, Colorado, Connecticut, the District of Columbia, Florida, Illinois, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Missouri, New Hampshire, New Mexico, New York, South Carolina, Oklahoma, Oregon, Pennsylvania, New York, New York, New York, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.
23AndMe probe launched to prevent customer DNA data from being sold to China and other bad actors
“23andme cannot auction the personal genetic information of millions of people without their consent,” New York Attorney General Letitia James said in a statement. “New Yorkers and many others across the country trust 23andMe for their personal information and have a right to know what happens with their information.”
23AndMe, a private genomics company in Mountain View, California, October 28, 2018. (Smith Collection/Gad/Getty Images)
A 23andme spokesman told Fox Business that the attorney general’s argument in the lawsuit was “no merit.”
“This sale is permitted under the 23andME Privacy Policy and applicable law,” the spokesman said. “We have requested bidders to adopt our policy and comply with applicable laws as a condition for participating in our sales process. Customers will continue to hold the same rights and protections in the hands of winning bidders.”
The remaining bidders, Regeneron Pharmaceuticals According to a 23andMe spokesman, the TTAM Research Institute “promised to comply with the 23andMe privacy policy and will continue to operate 23andMe, which is always operating.”
On February 1, 2024, 23andMe headquarters will take a walk through pedestrians in Sunnyvale, California. (Justin Sullivan/Getty Images)
In May, New York-based Regeneron announced that he had been appointed as a successful bidder in an auction of “virtually everything” of 23andme’s assets with a $256 million bid.
23AndMe Bankruptcy: Will your private data be protected?
23Andme subsequently set the stage for another auction with a $355 million bid from the TTAM Research Institute, founded by Anne Wojcicki.
Genetic testing company participated Chapter 11 Bankruptcy We will promote the sale of the business in March. In its bankruptcy petition, the company estimates the range of $100 million to $500 million for its assets, with estimated liabilities in the same range.
23AndMe was originally founded in 2006.
